GSS.AX ASX
Genetic Signatures Limited
1W: +1.3%
1M: -9.2%
3M: +25.4%
YTD: -43.6%
1Y: -72.8%
3Y: -84.7%
5Y: -94.8%
A$0.08 ($0.05)
+0.00 (+0.00%)
Weekly Expected Move ±11.7%
A$0
A$0
A$0
A$0
A$0
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Income Trends
Revenue
$14M
-9.1% ▼
5Y CAGR: -12.6%
Gross Profit
-$13M
-263.5% ▼
Operating Income
-$18M
+4.0% ▲
Net Income
-$14M
+30.3% ▲
EPS (Diluted)
$-0.06
+30.4% ▲
EBITDA
-$16M
+2.5% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Revenue | $35M | $17M | $10M | $16M | $14M |
| YoY Growth | +25.2% | -52.2% | -42.3% | +62.8% | -9.1% |
| Cost of Revenue | $28M | $30M | $5M | $8M | $27M |
| Gross Profit | $7M | -$13M | $4M | $8M | -$13M |
| Gross Margin | 20.4% | -75.2% | 44.1% | 48.9% | -88.0% |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $4M | $6M | $15M | $16M | $5M |
| Operating Expenses | $4M | $6M | $27M | $26M | $5M |
| Operating Income | $3M | -$19M | -$22M | -$18M | -$18M |
| Operating Margin | 8.4% | -111.5% | -228.7% | -116.2% | -122.8% |
| Interest Expense | $19K | $1K | $35K | $91K | $46K |
| Income Before Tax | $3M | -$18M | -$22M | -$20M | -$18M |
| Tax Expense | $1M | -$4M | -$4M | -$4M | -$4M |
| Net Income | $3M | -$14M | -$18M | -$20M | -$14M |
| Net Margin | 8.6% | -83.0% | -182.9% | -126.4% | -96.9% |
| EPS (Diluted) | $0.02 | $-0.10 | $-0.11 | $-0.09 | $-0.06 |
| EBITDA | $5M | -$13M | -$20M | -$16M | -$16M |
| Shares Outstanding | 149M | 147M | 165M | 227M | 227M |